Caution Against Overinterpretation of Results in the FENETRE Trial
-
By
-
Isaiah J. Miller
-
Sally S. Ong
-
June 15, 2026
-
Clinical Scorecard: Warnings Against Misinterpretation of Findings from the FENETRE Study
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Indefinite intravitreal anti-VEGF injection therapy and lifelong OCT monitoring. |
| Target Population | |
| Care Setting | |
Key Highlights
- Community optometrists demonstrated a false-negative rate of 3.8% compared to 7.8% in the hospital group.
- The study involved 704 adults across 17 NHS hospitals and 60 community optometry practices.
Guideline-Based Recommendations
Diagnosis
- Careful classification of cases, including a 'suspicious' category for uncertain diagnoses.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Indefinite anti-VEGF therapy and OCT monitoring are essential for managing nAMD.
Clinical Best Practices
Related Resources & Content
